Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
Kruzelock
Russell P
RP
The Institute for Drug Development, San Antonio, Texas, USA.
Short
William
W
D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D016503:Drug Delivery Systems; D015195:Drug Design; D005819:Genetic Markers; D006801:Humans; D009857:Oncogenes / Q000235:genetics; D010597:Pharmacogenetics / Q000639:trends*; D012307:Risk Factors
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D005819:Genetic Markers